betadex has been researched along with phytochlorin* in 4 studies
4 other study(ies) available for betadex and phytochlorin
Article | Year |
---|---|
β-Cyclodextrin Nanophotosensitizers for Redox-Sensitive Delivery of Chlorin e6.
The aim of this study is to prepare redox-sensitive nanophotosensitizers for the targeted delivery of chlorin e6 (Ce6) against cervical cancer. For this purpose, Ce6 was conjugated with β-cyclodextrin (bCD) via a disulfide bond, creating nanophotosensitizers that were fabricated for the redox-sensitive delivery of Ce6 against cancer cells. bCD was treated with succinic anhydride to synthesize succinylated bCD (bCDsu). After that, cystamine was attached to the carboxylic end of bCDsu (bCDsu-ss), and the amine end group of bCDsu-ss was conjugated with Ce6 (bCDsu-ss-Ce6). The chemical composition of bCDsu-ss-Ce6 was confirmed with Topics: Animals; beta-Cyclodextrins; Cell Line, Tumor; Chlorophyllides; Female; HeLa Cells; Humans; Nanoparticles; Oxidation-Reduction; Photochemotherapy; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Uterine Cervical Neoplasms | 2023 |
Redox-Sensitive and Folate-Receptor-Mediated Targeting of Cervical Cancer Cells for Photodynamic Therapy Using Nanophotosensitizers Composed of Chlorin e6-Conjugated β-Cyclodextrin via Diselenide Linkage.
The aim of this study was to fabricate a reactive oxygen species (ROS)-sensitive and folate-receptor-targeted nanophotosensitizer for the efficient photodynamic therapy (PDT) of cervical carcinoma cells. Chlorin e6 (Ce6) as a model photosensitizer was conjugated with succinyl β-cyclodextrin via selenocystamine linkages. Folic acid (FA)-poly(ethylene glycol) (PEG) (FA-PEG) conjugates were attached to these conjugates and then FA-PEG-succinyl β-cyclodextrin-selenocystamine-Ce6 (FAPEGbCDseseCe6) conjugates were synthesized. Nanophotosensitizers of FaPEGbCDseseCe6 conjugates were fabricated using dialysis membrane. Nanophotosensitizers showed spherical shapes with small particle sizes. They were disintegrated in the presence of hydrogen peroxide (H Topics: Animals; beta-Cyclodextrins; Cell Line; Cell Line, Tumor; Chlorophyllides; Female; Folate Receptors, GPI-Anchored; Folic Acid; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Oxidation-Reduction; Particle Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Uterine Cervical Neoplasms | 2021 |
pH-dependent complexation of hydroxypropyl-beta-cyclodextrin with chlorin e6: effect on solubility and aggregation in relation to photodynamic efficacy.
The activity of chlorin e6 (Ce6) in photodynamic therapy of cancers is significantly reduced by its propensity to form aggregates. It was postulated that disaggregation of Ce6 could be achieved with the use of hydroxypropyl-beta-cyclodextrin (HP-β-CD) through solubility enhancement.. An initial phase solubility study of Ce6 was conducted with various concentrations of HP-β-CD at three different pH conditions, i.e. pH 3, pH 5 and pH 7. Solubility-induced disaggregation of Ce6 was illustrated by fluorescence spectroscopy and singlet oxygen generation studies. Interaction between Ce6 and HP-β-CD was further demonstrated by solid-state characterization techniques. Inclusion complex formulations were tested for improved efficacy on squamous cancer cell lines.. Increase in Ce6 solubility was observed, especially at pH 7, indicating the formation of inclusion complex between Ce6 and HP-β-CD. This resulted in disaggregation of Ce6 aggregates illustrated by fluorescence spectroscopy. The mode of binding was predominated by H-bonding supported by temperature-dependent binding studies and molecular simulation work. The inclusion complex demonstrated improved photodynamic efficacy through enhanced singlet oxygen generation and phototoxicity on human oral squamous carcinoma cells.. pH-dependent complexation between Ce6- and HP-β-CD-induced disaggregation of Ce6 aggregates and the resultant formulations facilitated improved PDT efficacy on tested cancer cell lines. Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Calorimetry, Differential Scanning; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Chlorophyllides; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Compounding; Head and Neck Neoplasms; Humans; Hydrogen-Ion Concentration; Models, Molecular; Mouth Neoplasms; Photochemotherapy; Photosensitizing Agents; Porphyrins; Powder Diffraction; Singlet Oxygen; Solubility; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Squamous Cell Carcinoma of Head and Neck; Thermodynamics; Time Factors | 2016 |
Programmed photosensitizer conjugated supramolecular nanocarriers with dual targeting ability for enhanced photodynamic therapy.
A programmed supramolecular nanocarrier was developed for multistage targeted photodynamic therapy. This smart nanocarrier exhibited enhanced cellular uptake and controlled mitochondria targeting, as well as an excellent photodynamic therapeutic effect after light irradiation. Topics: Amino Acid Sequence; Apoptosis; beta-Cyclodextrins; Breast Neoplasms; Cell Proliferation; Chlorophyllides; Drug Carriers; Female; Humans; Light; MCF-7 Cells; Microscopy, Confocal; Mitochondria; Nanoparticles; Peptides; Photochemotherapy; Photosensitizing Agents; Porphyrins | 2016 |